New Rembra RT and Areta RT [1] CT platforms drive accuracy and efficiency in radiation therapy with advanced workflows and long-term value

新推出的Rembra RT和Areta RT [1] CT平台通过先进的工作流程和长期价值推动了放射治疗的准确性和效率。

Philips debuts helium-free [2] BlueSeal RT 1.5T 70cm MR system with AI-powered SmartSpeed Precise, expanding its leadership in sustainable MR for radiation oncology

飞利浦推出了无氦 BlueSeal RT 1.5T 70cm 磁共振系统，该系统配备了人工智能驱动的 SmartSpeed Precise 技术，进一步巩固了其在用于放射肿瘤学的可持续磁共振领域的领导地位。

Amsterdam, the Netherlands – At the American Society for Radiation Oncology (

阿姆斯特丹，荷兰——在美国放射肿瘤学会（

ASTRO

天体

) 2025 Annual Meeting,

) 2025年年度会议，

Royal Philips

皇家飞利浦

(NYSE: PHG, AEX: PHIA), a global leader in health technology, will introduce groundbreaking additions in radiation oncology: the Philips Rembra RT and Philips Areta RT CT platforms, and the latest helium-free [2] BlueSeal RT 1.5T MR system. Designed to help radiation oncology teams deliver highly accurate, efficient, and patient-centered care, innovative technologies like the new NanoPanel Precise XD detector, built for AI and the AI-based Smartspeed Precise, represent a significant step forward in tackling the growing complexities of radiation therapy planning..

（纽约证券交易所代码：PHG，阿姆斯特丹泛欧交易所代码：PHIA），作为全球健康技术的领导者，将推出放射肿瘤学领域的突破性创新：飞利浦Rembra RT和飞利浦Areta RT CT平台，以及最新的无氦[2] BlueSeal RT 1.5T磁共振系统。这些创新技术旨在帮助放射肿瘤学团队提供高度精确、高效且以患者为中心的护理，例如专为人工智能设计的全新NanoPanel Precise XD探测器和基于人工智能的Smartspeed Precise，标志着在应对放射治疗规划日益复杂化的挑战中迈出了重要一步。

Setting new standards in CT simulation with speed, accuracy, and long-term value

在CT模拟中以速度、精度和长期价值设定新标准

CT imaging is the foundation of precision in radiation therapy planning, delivering accuracy to guide treatment. But as oncology teams face mounting demands for precision, efficiency, and consistency amid staffing and resource pressures, a new era of CT simulation is rising to meet the challenge.

CT成像是放射治疗计划中精确性的基础，为治疗提供准确性。但随着肿瘤学团队在人员和资源压力下面临越来越多的对精确性、效率和一致性的需求，一个全新的CT模拟时代正在崛起以应对这些挑战。

Philips’ new

飞利浦的新

Rembra RT and Areta RT systems

Rembra RT 和 Areta RT 系统

are designed to make cancer treatment planning faster and more accurate.  These advanced scanners produce clearer, more consistent images so doctors can see tumors in greater detail and plan treatments with confidence. They also save valuable time with ultra-fast image reconstruction speeds up to 106 images per second, and easy-to-use touchscreen gantry controls that help 91% of care teams work more efficiently [3].

旨在使癌症治疗规划更快速、更准确。这些先进的扫描仪生成更清晰、更一致的图像，让医生能够更详细地观察肿瘤并有信心地制定治疗方案。它们还通过超快的图像重建速度（每秒高达106幅图像）和易于使用的触摸屏机架控制节省了宝贵的时间，助力91%的护理团队更高效地工作[3]。

A wide 85 cm extended field of view and next-generation 4DCT imaging capabilities can capture a full respiratory cycle in one scan up to 500 scan seconds with breath rates of 4-40 breaths per minute. .

宽达85厘米的扩展视场和下一代4DCT成像功能可以在一次扫描中捕捉完整的呼吸周期，最长扫描时间可达500秒，呼吸频率为每分钟4至40次。

Beyond imaging, the systems support remote collaboration for planning and training, helping care teams stay connected and efficient without adding extra staff. And with Philips’ industry-first Tube for Life Guarantee and a design for which 20 years of service could be provided (provided commercial upgrades and maintenance), hospitals gain reliable, long-term value while keeping costs lower.

除了成像功能外，这些系统还支持远程协作进行规划和培训，帮助护理团队保持联系和高效，而无需增加额外员工。凭借飞利浦行业首创的“Tube for Life”保障以及可提供20年服务的设计（在提供商业升级和维护的前提下），医院在降低费用的同时获得了可靠且长期的价值。

Patients also benefit directly, with a high-performance table that allows flexible positioning, faster workflows that shorten waiting times, and shared-use radiology capabilities on Rembra RT to maximize department efficiency..

患者也直接受益，高性能的治疗床能够灵活调节位置、加快工作流程从而缩短等待时间，并且Rembra RT的共用放射功能可以提高科室效率。

“Philips invented CT Simulation and introduced the industry’s first Big Bore RT system,” said Dan Xu, Business Leader of CT at Philips. “With Rembra RT and Areta RT, we’re once again setting new standards in radiation therapy, empowering care teams with the precision, dependability, and speed they need to deliver the best outcomes for patients.”.

“飞利浦发明了CT模拟技术，并推出了业界首个大孔径放疗系统，”飞利浦CT业务负责人徐丹表示。“通过Rembra RT和Areta RT，我们再次树立了放射治疗的新标准，为医疗团队提供实现最佳患者效果所需的精准性、可靠性和速度。”

Philips is also currently working with

飞利浦目前也在与

MVision AI

MVision AI

to explore opportunities to include MVision AI’s Contour+ AI-powered auto-segmentation software with Philips CT simulators, including the new Rembra RT and Areta RT systems.  Contour+ delivers fast and precise automatic delineation of organs at risk and lymph node areas.

探索将MVision AI的Contour+ AI自动分割软件与飞利浦CT模拟器（包括新的Rembra RT和Areta RT系统）整合的机会。Contour+能够快速且精确地自动描绘危及器官和淋巴结区域。

Philips expands MR leadership with helium-free BlueSeal RT [4]

飞利浦通过无氦BlueSeal RT扩展MR领导地位 [4]

Alongside its newest CT innovations, Philips is introducing BlueSeal MR RT in North America [5], the company’s latest helium-free [2] 1.5T 70cm MR system designed for radiation oncology. Powered by AI-based

Philips公司在北美推出了BlueSeal MR RT [5]，这是该公司最新的无氦[2] 1.5T 70cm磁共振系统，专为放射肿瘤学设计。该系统由基于人工智能的技术驱动。

SmartSpeed Precise

智能速度 精准

acceleration software, BlueSeal RT enables enhanced simulation confidence.

加速软件，BlueSeal RT 能够增强模拟的可信度。

MR plays an increasingly vital role in radiation therapy, enabling clinicians to visualize tumors and surrounding healthy tissue with far greater detail, which is essential for planning precise treatments. By combining sustainability with advanced imaging, BlueSeal RT transforms therapy planning with enhanced simulation confidence, reducing registration errors to help protect healthy organs.

磁共振在放射治疗中发挥着越来越重要的作用，使临床医生能够以更高的细节观察肿瘤及周围健康组织，这对于制定精确的治疗计划至关重要。通过将可持续性与先进成像技术相结合，BlueSeal RT通过增强模拟信心彻底改变治疗规划，减少配准误差，有助于保护健康器官。

In addition, MR-only imaging with MRCAT simplifies workflows. With full MR-only simulation protocols in as little as 10 minutes, patients also benefit, experiencing shorter scans that improve comfort and overall experience, especially for those wearing a mask. .

此外，使用 MRCAT 的纯 MR 成像简化了工作流程。通过在短短 10 分钟内完成完整的纯 MR 模拟协议，患者也从中受益，扫描时间缩短，提高了舒适度和整体体验，尤其是对于佩戴面罩的患者。

With approximately 2,000 helium-free [2] MR scanners installed worldwide, Philips is driving the shift to sustainable MR. BlueSeal RT extends this leadership into radiotherapy by addressing a key challenge for oncology departments: installing MR systems in complex clinical environments such as Radiation Oncology departments.

在全球大约安装了2000台无氦[2]磁共振扫描仪的背景下，飞利浦正在推动磁共振向可持续发展的转变。BlueSeal RT通过解决肿瘤科面临的一个关键挑战，将这种领导地位扩展到放射治疗领域：即在放射肿瘤科等复杂的临床环境中安装磁共振系统。

Its light-weight, vent-pipe-free design opens new siting possibilities - whether in basements, bunkers, or higher floors - while also lowering cost and energy use through helium-free [2] operation and PowerSave+ efficiency..

其轻量化、无通风管道的设计开辟了新的选址可能性——无论是在地下室、地堡还是更高的楼层——同时通过无氦气[2]运行和PowerSave+效率降低了成本和能耗。

“BlueSeal RT is leading the way in MR for radiotherapy,” said Ioannis Panagiotelis, PhD, Business Leader MR at Philips. “By combining helium-free [2] sustainability with AI-powered acceleration, we’re enabling radiation oncology teams to plan and simulate with greater speed, accuracy, and confidence—while enhancing the patient experience.”.

“BlueSeal RT在放射治疗的MR领域处于领先地位，”飞利浦MR业务主管Ioannis Panagiotelis博士表示，“通过将无氦[2]可持续性与人工智能加速相结合，我们使放射肿瘤学团队能够以更高的速度、精度和信心进行规划和模拟，同时提升患者的体验。”

“Radiation oncology teams need transformative innovation to meet today’s accuracy, workflow, and cost challenges,” said Christopher M. Freese, MD, The Christ Hospital. “With Rembra RT, Areta RT, and BlueSeal RT, Philips is setting new standards for precision and efficiency in radiation therapy across CT and MR.” .

“放射肿瘤学团队需要通过变革性创新来应对当今在准确性、工作流程和成本方面的挑战，”基督医院的克里斯托弗·M·弗里塞医学博士说道。“借助Rembra RT、Areta RT和BlueSeal RT，飞利浦正在为CT和MR领域的放射治疗精度和效率设立新标准。”

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home..

皇家飞利浦（纽约证券交易所代码：PHG，阿姆斯特丹证券交易所代码：PHIA）是一家领先的健康技术公司，专注于通过有意义的创新来改善人们的健康和福祉。飞利浦以患者和民众为中心的创新利用先进技术，并结合深入的临床和消费者洞察，为消费者提供个人健康解决方案，为医疗保健提供者及其患者提供专业的健康解决方案，涵盖医院和家庭场景。

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,300 employees with sales and services in more than 100 countries.

总部位于荷兰的飞利浦是诊断影像、超声、影像引导治疗、监测和企业信息学以及个人健康领域的领导者。2024年销售额达到180亿欧元，在全球100多个国家拥有约67,300名员工，负责销售和服务。